These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19616261)

  • 1. Proteomics and opportunities for clinical translation in urological disease.
    Vaezzadeh AR; Steen H; Freeman MR; Lee RS
    J Urol; 2009 Sep; 182(3):835-43. PubMed ID: 19616261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities for discovery of disease biomarkers using urine proteomics.
    Kentsis A
    Pediatr Int; 2011 Feb; 53(1):1-6. PubMed ID: 20840485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and peptidomics: moving toward precision medicine in urological malignancies.
    Di Meo A; Pasic MD; Yousef GM
    Oncotarget; 2016 Aug; 7(32):52460-52474. PubMed ID: 27119500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Lindsey ML; Mayr M; Gomes AV; Delles C; Arrell DK; Murphy AM; Lange RA; Costello CE; Jin YF; Laskowitz DT; Sam F; Terzic A; Van Eyk J; Srinivas PR;
    Circulation; 2015 Sep; 132(9):852-72. PubMed ID: 26195497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary exosomes and proteomics.
    Moon PG; You S; Lee JE; Hwang D; Baek MC
    Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.
    Chen Z; Kim J
    BMC Urol; 2016 Mar; 16():11. PubMed ID: 27000794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.
    Lam MP; Ping P; Murphy E
    J Am Coll Cardiol; 2016 Dec; 68(25):2819-2830. PubMed ID: 28007144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of the art for enhancing urine biomarker discovery.
    Harpole M; Davis J; Espina V
    Expert Rev Proteomics; 2016 Jun; 13(6):609-26. PubMed ID: 27232439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics--a blessing or a curse? Application of proteomics technology to transplant medicine.
    Kienzl-Wagner K; Pratschke J; Brandacher G
    Transplantation; 2011 Sep; 92(5):499-509. PubMed ID: 21716169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
    Albalat A; Mischak H; Mullen W
    Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics technologies and challenges.
    Cho WC
    Genomics Proteomics Bioinformatics; 2007 May; 5(2):77-85. PubMed ID: 17893073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
    Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
    Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics and urine analysis: a potential promising new tool in urology.
    Kommu S; Sharifi R; Edwards S; Eeles R
    BJU Int; 2004 Jun; 93(9):1172-3. PubMed ID: 15180597
    [No Abstract]   [Full Text] [Related]  

  • 16. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics: Clinical and research applications in respiratory diseases.
    Norman KC; Moore BB; Arnold KB; O'Dwyer DN
    Respirology; 2018 Nov; 23(11):993-1003. PubMed ID: 30105802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teaching molecular genetics: Chapter 3--Proteomics in nephrology.
    Groenen PJ; van den Heuvel LP
    Pediatr Nephrol; 2006 May; 21(5):611-8. PubMed ID: 16572342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.
    Alex P; Gucek M; Li X
    Inflamm Bowel Dis; 2009 Apr; 15(4):616-29. PubMed ID: 18844215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
    Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
    Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.